share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Samuels Theodore R. II

SEC announcement ·  Apr 3 06:46
Summary by Futu AI
Samuels Theodore R. II, associated with Bristol-Myers Squibb (BMY), was involved in a transaction on 03/31/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Samuels to the issuer was not specified, and there was no information provided regarding the number of shares held after the action.
Samuels Theodore R. II, associated with Bristol-Myers Squibb (BMY), was involved in a transaction on 03/31/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Samuels to the issuer was not specified, and there was no information provided regarding the number of shares held after the action.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.